About ATA
qPCR is Powerful—but Underutilized.
Most labs stop at detection. Most providers don’t have time to interpret. The result? Delayed treatment, broad-spectrum antibiotics, and a growing resistance problem.
ATA provides real-time, clinical interpretation of qPCR results—so the right antibiotic is prescribed, faster.
We support diagnostic labs, physician offices, and long-term care facilities by delivering precise, evidence-based guidance for targeted therapy. Our pharmacists and infectious disease experts work directly with clinical teams to help reduce resistance, improve patient outcomes, and support stewardship efforts, without disrupting existing workflows.
Who We Support
We work with healthcare leaders who value precision and accountability:
Independent & Regional Labs
Differentiate your offering by pairing diagnostic results with timely prescribing guidance.
POLs (Physician Office Labs)
Get expert support for interpreting complex panels without hiring additional staff.
Healthcare Management Groups
Bundle lab interpretation with your service model to increase provider satisfaction.
Long-Term Care Operators
Reduce hospitalizations and antibiotic misuse with faster, more accurate treatment decisions.
Laboratory Panel Consults
Arrange organisms to benefit the physician.
Mobile and Nursing Networks
Ensure your clinicians are equipped with clear, evidence-based recommendations in the field.
Our Mission
To advance clinical care and slow the spread of antibiotic resistance by turning molecular diagnostics into actionable prescribing decisions.
We don’t run tests. We don’t sell panels. We interpret data accurately, consistently, and on time.
Our Values
Precision
Every recommendation is backed by pharmacology, resistance patterns, and current evidence.
Integrity
We don’t guess. We don’t speculate. We only recommend when the data supports it.
Clarity
Providers don’t need more data—they need clear next steps. That’s what we provide.
Stewardship
We support institutions that are serious about targeted therapy and responsible prescribing.
Collaboration
We act as an extension of your team, helping you deliver better care without increasing overhead.
Meet the Team
ATA was founded on June 15, 2018, with a clear mission: to deliver better antibiotic guidance through molecular data interpretation.
From a small, focused team, we’ve grown into a network of 20+ PharmDs and reviewed over 1 million reports—all grounded in clinical rigor and service excellence.
We’re proud to introduce the pharmacists setting a new standard in molecular infectious disease care.
Executive Management
Dr. Robin Prince
Chief Executive Officer
With experience spanning pediatrics, geriatrics, long-term care, and retail pharmacy, Dr. Prince is a nationally respected leader in clinical pharmacy innovation. She pioneered the integration of therapeutic guidance with molecular diagnostics and continues to drive ATA’s mission for precision medicine and stewardship.
Dr. Robin Ritter
Chief Operating Officer
A veteran of over 30 years in community pharmacy, including ownership and long-term care specialization, Dr. Ritter brings practical insight and operational excellence to ATA. She’s been with the company since its founding and plays a key role at ATA in antibiotic resistant therapy development.
Jake Nance
Senior Director of Operations
Jake Nance has over 7 years of experience in the PCR Diagnostic Industry. Jake’s experience includes management, logistics, customer relations, operations, and information software development. Mr. Nance has worked with different innovative laboratories consulting and improving operations across the country. Mr. Nance graduated from the University of Arkansas with a Bachelor of Science in Business Administration. Jake has been with ATA since 2019.
Founders & Specialty Directors
Dr. Joy Cherry
Director of Pharmacogenetics – PGX specialist since 2011, with deep hospital and VA experience.
Dr. Dallas Hofmann
Director of Wounds & Infectious Disease – Microbiology-focused community pharmacist.
Dr. Alexis Luckey
Director of Microbial Stewardship & Critical Care – Formerly at Cleveland Clinic and now Methodist Le Bonheur South.
Clinical Leadership
Dr. Colton Moorman
Director of Genitourinary Infectious Disease – Hospital-trained PharmD focused on outcome optimization.
Dr. David Kelley
Director of Respiratory –Acute care specialist and proven clinical leader with military and global experience.
Dr. Peni Duncan
Director of Urinary Infectious Disease – Experienced in hospital, long-term care, and compounding pharmacy. MBA from The Citadel.
Specialist Team
Dr. Carolyn Peavey
Community Specialist
Dr. Tanya Clark
Community Specialist
Dr. Brad Pate
Community Specialist
Dr. Margaret Pate
Hospital Specialist
Dr. Brett Lowery
Hospital Specialist
Dr. Quincy Bing
Oncology Specialist
Dr. John Ekstrand
Community Specialist
Dr. Nicole Klones
Hospital & Community Specialist
Dr. Charles Morris
Community Specialist
Dr. Mollie Harlow
Community Specialist
Dr. Cody Birchenough
Hospital & Community Specialist
Dr. Lori Myers
Community Specialist
If your organization is serious about improving outcomes, reducing resistance, and delivering more value from every test—we’re ready to help.